Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | BMY | GSK | ||
| Company | Csl Ltd ADR | Bristol-Myers Squibb Company | Gsk Plc ADR | ||
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | ||
| Open | 91.1400 | 45.09 | 41.66 | ||
| High | 91.7500 | 45.38 | 42.00 | ||
| Low | 90.1700 | 44.61 | 41.66 | ||
| Last | 90.5700 | 44.61 | 41.70 | ||
| Change | +0.9700 | -0.24 | +0.59 | ||
| % Change | +1.08% | -0.54% | +1.44% | ||
| Volume | 33,509 | 8,958,310 | 2,320,714 | ||
| 20-Day Average Volume | 36,115 | 13,139,104 | 3,074,995 | ||
| Previous Close | 89.6000 | 44.85 | 41.11 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 90.5523 | 49.06 | 40.74 | ||
| 20-Day Raw Stochastic | 54.69% | 3.94% | 85.59% | ||
| 20-Day Relative Strength | 47.76% | 28.78% | 54.24% | ||
| Weighted Alpha | -7.71 | -35.25 | +16.29 | ||
| Today's Opinion | 8% Buy | 88% Sell | 56% Buy | ||
| Previous Opinion | 8% Sell | 88% Sell | 56% Buy | ||
| Last Month's Opinion | 72% Buy | 24% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.57% since 04/22/24 | -9.05% since 04/22/24 | +2.76% since 04/22/24 | ||
| Low | 88.8800 on 04/25/24 | 44.34 on 04/26/24 | 40.60 on 04/23/24 | ||
| High | 91.9100 on 04/24/24 | 49.47 on 04/23/24 | 42.00 on 04/29/24 | ||
| 1-Month | |||||
| %Chg | -3.95% since 03/28/24 | -17.58% since 03/28/24 | -2.71% since 03/28/24 | ||
| Low | 85.9600 on 04/22/24 | 44.34 on 04/26/24 | 39.15 on 04/18/24 | ||
| High | 94.3900 on 04/02/24 | 54.23 on 04/01/24 | 42.87 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | -6.86% since 01/29/24 | -10.38% since 01/29/24 | +6.78% since 01/29/24 | ||
| Low | 85.9600 on 04/22/24 | 44.34 on 04/26/24 | 38.93 on 01/30/24 | ||
| High | 99.5400 on 01/31/24 | 55.03 on 03/13/24 | 43.84 on 03/07/24 | ||
| 6-Month | |||||
| %Chg | +23.43% since 10/27/23 | -12.40% since 10/27/23 | +20.69% since 10/27/23 | ||
| Low | 71.5100 on 10/30/23 | 44.34 on 04/26/24 | 33.67 on 11/02/23 | ||
| High | 99.9500 on 12/27/23 | 55.03 on 03/13/24 | 43.84 on 03/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 86,598,848 | 90,900,144 | 85,198,008 | ||
| Shares Outstanding, K | 966,505 | 2,026,759 | 2,072,440 | ||
| Annual Sales | 13,310,000,000 | 45,006,000,000 | 37,725,000,000 | ||
| Annual Net Income | 2,194,000,000 | 8,025,000,000 | 6,129,940,000 | ||
| Last Quarter Sales | N/A | 11,477,000,000 | 9,980,060,000 | ||
| Last Quarter Net Income | N/A | 1,762,000,000 | 433,200,000 | ||
| 60-Month Beta | 0.73 | 0.39 | 0.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -4.40 on 04/25/24 | 0.72 on 01/31/24 | ||
| Latest Earnings Date | 09/27/23 | 04/25/24 | 05/01/24 | ||
| Most Recent Dividend | 0.545 on 03/11/24 | 0.600 on 04/04/24 | 0.397 on 02/22/24 | ||
| Next Ex-Dividends Date | 03/11/24 | 04/04/24 | 02/22/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.08 | 10.63 | ||